Kelly Rafferty, LPN | |
4690 Winding Creek Trl, Abrams, WI 54101-9576 | |
(920) 819-6197 | |
Not Available |
Full Name | Kelly Rafferty |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 4690 Winding Creek Trl, Abrams, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265863906 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 302119-031 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kelly Rafferty, LPN 4690 Winding Creek Trl, Abrams, WI 54101-9576 Ph: () - | Kelly Rafferty, LPN 4690 Winding Creek Trl, Abrams, WI 54101-9576 Ph: (920) 819-6197 |
News Archive
Combining the investigational agents REGN910 and aflibercept yielded statistically significant improvements in antitumor effects in animal models compared with either agent alone, according to results presented at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, held Nov. 12-16, 2011.
To help prevent possible complications such as nonunion at large fracture sites, researchers have developed a cartilage matrix that mimics the early stages of repair and provides the essential structural and biological properties needed by bone-forming cells to divide and grow.
TELA Bio, Inc., a surgical reconstruction company leading the development and commercialization of Reinforced BioScaffolds (RBSs) for soft tissue repair, today announced the company's OviTex RBSs have been implanted in more than 100 hernia repair procedures since receiving U.S. Food and Drug Administration 510(k) clearance in June 2016.
Thirty-Day Readmission Rates For Medicare Beneficiaries By Race And Site of Care - Using national Medicare data on 30-day readmissions after hospitalizations for heart attack, congestive heart failure and pneumonia, the authors report that "black patients had 13% higher odds of all-cause 30-day readmission than white patients.
A new process that helps unmask genetic mutations by separating chromosomes so they can be studied individually may improve the diagnostic yield of some genetic tests, according to findings of a Colon Cancer Family Registry study published today in the Journal of the American Medical Association.
› Verified 8 days ago